Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorParis Translational Research Center for Organ Transplantation

About this trial

The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.

Eligibility criteria

Qualifiers

* Age ≥ 18 years

Fluency in French or English

Electronic consent given

Disqualifiers

Severe cognitive impairment preventing comprehension

Technical inability to access the questionnaire

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 11 trial groups

11

Trial groups

See each trial group below.